Drug Topics

FEBRUARY 2, 2023

After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR

358

358

PharmaVoice

FEBRUARY 2, 2023

The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target.

240

240

Drug Topics

FEBRUARY 2, 2023

Experts say Democrats and Republicans could work together on a variety of policy issues over the course of the year.

247

247

PharmaVoice

FEBRUARY 2, 2023

A menagerie of earnings calls this week showed where the Big Pharma players stand in 2023.

148

148

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Store News

FEBRUARY 2, 2023

​​​​​​​Cardinal Health’s second quarter revenue increased 13% to $51.5 billion from the prior year period.

120

120

STAT

FEBRUARY 2, 2023

WASHINGTON — A majority of Americans support banning all tobacco products, according to a new poll published by researchers at the Centers for Disease Control and Prevention. The survey , which was published Thursday in the peer-reviewed journal Preventing Chronic Disease, asked 6,455 people nationwide: “To what extent would you support a policy to prohibit the sale of all tobacco products?

117

117

Fierce Healthcare

FEBRUARY 2, 2023

Payers, providers clash over scope of CMS review of ACA's essential health benefits rking Thu, 02/02/2023 - 17:40

105

105

Pharmaceutical Technology

FEBRUARY 2, 2023

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD.

FDA 105

FDA 105

Fierce Healthcare

FEBRUARY 2, 2023

Patients overestimate how well they recall diagnoses, care after discharge: study dmuoio Thu, 02/02/2023 - 16:44

103

103

STAT

FEBRUARY 2, 2023

WASHINGTON  — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has learned.   “ Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell confirmed.

100

100

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

FEBRUARY 2, 2023

Why more granular racial, ethnic data could improve maternal outcomes fdiamond Thu, 02/02/2023 - 13:51

99

99

STAT

FEBRUARY 2, 2023

There are about as many Americans living with addiction as there are Americans living with cancer — but you wouldn’t know it based on the world of venture capital. In the past decade, investment firms have poured roughly 270 times more money into developing cancer drugs than addiction cures, according to a new report from BIO, the biotechnology industry trade group.

99

99

Fierce Healthcare

FEBRUARY 2, 2023

CMS seeks to make quality measures more ‘universal’ in rollout of new program rking Thu, 02/02/2023 - 11:51

98

98

DiversifyRx

FEBRUARY 2, 2023

What is the DIR Fee Apocalypse? Everything You Need To Know. DIR Fees are the bane of any pharmacy owner. Make sure you are ready for the changes coming in 2024. If you’re a pharmacy owner, you know DIR fees and how they can negatively impact the cash flow of your pharmacy. What many pharmacy owners are not aware of yet, is the DIR changes coming in January 2024.

Independent Pharmacies 98

Independent Pharmacies 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

FEBRUARY 2, 2023

White House unveils CancerX innovation accelerator, new funding for cancer screenings on Moonshot anniversary hlandi Thu, 02/02/2023 - 16:20

98

98

InCrowd

FEBRUARY 2, 2023

Tyana Newbill is a Member Outreach Specialist for Apollo Intelligence. Get to know more about her below! You work with our sister research brands InCrowd and OpinionSite. Can you describe your role within the organizations? I originally joined the Apollo/InCrowd/OpinionSite family as a Member Outreach Specialist for the Executive Recruitment Team.

19

19

Fierce Healthcare

FEBRUARY 2, 2023

GAO: Data on use of Medicare Advantage supplemental benefits are lacking pminemyer Thu, 02/02/2023 - 13:55

98

98

The Checkup by Singlecare

FEBRUARY 2, 2023

Inflation is driving up the cost of living in the United States, and prescription prices are no exception. Perhaps more than ever, affordability is an important factor for physicians to consider when prescribing medications to their patients. When available, generic medications can help to reduce the cost of medications for many health conditions. But what if no generic exists, and you have to use an expensive brand-name drug to manage your condition?

Insurance 98

Insurance Mail-Order Pharmacies Dosage 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

FEBRUARY 2, 2023

Bayer, EMD Serono announce 340B restrictions in wake of pharma's courtroom win dmuoio Thu, 02/02/2023 - 12:27

98

98

Pharmaceutical Technology

FEBRUARY 2, 2023

If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.

FDA 98

FDA 98

European Pharmaceutical Review

FEBRUARY 2, 2023

AMJEVITA (adalimumab-atto), a biosimilar to Humira ® (adalimumab), is now available in the US. Amgen’s AMJEVITA was the first biosimilar to Humira approved by the US Food and Drug Administration (FDA), in 2016. The active ingredient in the anti-TNF-α monoclonal antibody has the same amino acid sequence as Humira. The Humira biosimilar will be available in prefilled syringe and autoinjector presentations to support dosing in each of the approved indications.

FDA 98

FDA 98

Drug Store News

FEBRUARY 2, 2023

The organization publicly commends the administration’s efforts to standardize plan choice by requiring generic drugs be placed on generic tiers and brand-name drugs on brand-name tiers.

98

98

Fierce Pharma

FEBRUARY 2, 2023

Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 - 11:20

98

98

Drug Store News

FEBRUARY 2, 2023

Walmart's new look includes brighter lighting, fashionable mannequins, colorful makeup displays, more spacious aisles and pet supplies.

98

98

European Pharmaceutical Review

FEBRUARY 2, 2023

The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. Three categories were available for entry in the Exhibitor Innovations section. The winning products were: Drug delivery innovation: UniSafe ® reusable connected auto-injector by Owen Mumford Pharmaceutical Services Packaging innovation: PACKSYS GmbH for ampoule dispenser Sustainability initiative: Körber P

Packaging 98

Packaging Medication Delivery 98

STAT

FEBRUARY 2, 2023

China’s massive Covid-19 crisis, sparked in part by the country’s rolling back its strict zero-Covid policies in early December, has seen millions of people infected with SARS-CoV-2. Making the problem worse is that supplies of name-brand Covid-19 drugs are few and far between, and generics of these drugs won’t be available in China due to failed manufacturer negotiations.

97

97

Drug Store News

FEBRUARY 2, 2023

The skin care brand was named the fastest-growing skin care brand of the last year according to NielsenIQ.

97

97

STAT

FEBRUARY 2, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

Hospitals 97

Hospitals 97

Drug Store News

FEBRUARY 2, 2023

CVS’ one+other is a beauty and personal care brand that celebrates self-expression and embraces individuality with more than 200 self-care essentials.

97

97

European Pharmaceutical Review

FEBRUARY 2, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved RINVOQ ® ▼ (upadacitinib), the first oral advanced therapy for adults with moderately to severely active Crohn’s disease (CD). This approval for Great Britain marks the first marketing authorisation globally for the use of upadacitinib in CD. Treating Crohn’s disease “There have been limited new treatment options approved for Crohn’s disease in recent years and many people struggle to stay in remission, demonstrati

Hospitals 94

Hospitals 94

Drug Store News

FEBRUARY 2, 2023

Dr Pepper’s new strawberries and cream beverage features the original 23 signature flavors of the brand, as well as a swirl of strawberry flavors and a creamy finish, the company said.

97

97

STAT

FEBRUARY 2, 2023

WASHINGTON — The new Democratic leadership team in Congress is pretty much the New York hospital lobby’s dream team. Senate Majority Leader Chuck Schumer (D-N.Y.) has long been an ally of the Greater New York Hospital Association, often pushing for more funding for teaching slots at hospitals. He goes back decades with the lobby’s CEO, Kenneth Raske.

Hospitals 91

Hospitals 91

Drug Store News

FEBRUARY 2, 2023

Meijer has rolled out a line of products featuring the art of Dana Powell-Smith, Melina Brann and Shaunt'e Lewis.

96

96